(Q54311931)

27 May 2018

title

Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias. (English)

1 reference

27 May 2018

author

Douglas P. Zipes

3

1 reference

27 May 2018

author name string

K F Browne

1

1 reference

27 May 2018

E N Prystowsky

2

1 reference

27 May 2018

D A Chilson

4

1 reference

27 May 2018

J J Heger

5

1 reference

27 May 2018

language of work or name

English

0 references

publication date

1 March 1984

1 reference

27 May 2018

Journal of the American College of Cardiology

published in

1 reference

27 May 2018

volume

3

1 reference

27 May 2018

issue

3

1 reference

27 May 2018

page(s)

857-864

1 reference

27 May 2018

Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980265-X

7 January 2021

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980265-X

7 January 2021

Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980265-X

7 January 2021

Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980265-X

7 January 2021

Haemodynamic effects of intravenous disopyramide in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2884%2980265-X

7 January 2021

10.1016/S0735-1097(84)80265-X

Identifiers

DOI

1 reference

27 May 2018

PubMed ID

6693656

1 reference

27 May 2018